Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Oncotarget|June 23, 2018
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastasesSven H Loosen, Frank Tacke, Marcel Binnebosel, et al.
Clinical and Translational Science|March 31, 2021
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignanciesTheresa H Wirtz, Sven H Loosen, Max Schulze-Hagen, et al.
Biomedicines|September 28, 2021
Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill PatientsBerkan Kurt, Lukas Buendgens, Theresa H Wirtz, et al.
BJC Reports|September 26, 2024
Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgeryLisa Heinrichs, Georg Fluegen, Sven H Loosen, et al.
Critical Care Explorations|August 25, 2020
Skeletal Muscle Composition Predicts Outcome in Critically Ill PatientsSven H Loosen, Maximilian Schulze-Hagen, Tobias Püngel, et al.
Carcinogenesis|February 27, 2019
High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinomaSven H Loosen, Frank Tacke, Niklas Püthe, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill PatientsTobias Puengel, Beate Weber, Theresa H Wirtz, et al.
Cancers|September 23, 2022
Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract CancerSven H Loosen, Justus Halpaap, Simon Labuhn, et al.
Frontiers in Oncology|April 19, 2021
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor TherapySven H Loosen, Joao Gorgulho, Markus S Jördens, et al.
Plos One|April 16, 2021
CT-based determination of excessive visceral adipose tissue is associated with an impaired survival in critically ill patientsTheresa H Wirtz, Sven H Loosen, Maximilian Schulze-Hagen, et al.
Pageof 19